Literature DB >> 31245420

Rising trends in intrahepatic cholangiocarcinoma incidence and mortality: getting at the root cause.

Mustafa Raoof1, Gagandeep Singh1.   

Abstract

Entities:  

Year:  2019        PMID： 31245420      PMCID： PMC6561886          DOI： 10.21037/hbsn.2019.01.15

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

1.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.

Authors:  T Patel
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

2.  Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.

Authors:  S D Taylor-Robinson; M B Toledano; S Arora; T J Keegan; S Hargreaves; A Beck; S A Khan; P Elliott; H C Thomas
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 3.  Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.

Authors:  William C Palmer; Tushar Patel
Journal:  J Hepatol       Date:  2012-03-13       Impact factor: 25.083

4.  The impossibility of separating age, period and cohort effects.

Authors:  Andrew Bell; Kelvyn Jones
Journal:  Soc Sci Med       Date:  2013-05-04       Impact factor: 4.634

Review 5.  Cholangiocarcinoma.

Authors:  Shahid A Khan; Howard C Thomas; Brian R Davidson; Simon D Taylor-Robinson
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321

6.  Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.

Authors:  Tania M Welzel; Katherine A McGlynn; Ann W Hsing; Thomas R O'Brien; Ruth M Pfeiffer
Journal:  J Natl Cancer Inst       Date:  2006-06-21       Impact factor: 13.506

7.  Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

Authors:  Yasser H Shaib; Jessica A Davila; Kathryn McGlynn; Hashem B El-Serag
Journal:  J Hepatol       Date:  2004-03       Impact factor: 25.083

8.  Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification.

Authors:  Gia L Tyson; Jawad A Ilyas; Zhigang Duan; Linda K Green; Mamoun Younes; Hashem B El-Serag; Jessica A Davila
Journal:  Dig Dis Sci       Date:  2014-09-10       Impact factor: 3.199

9.  Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?

Authors:  Shahid A Khan; Shireen Emadossadaty; Nimzing G Ladep; Howard C Thomas; Paul Elliott; Simon D Taylor-Robinson; Mireille B Toledano
Journal:  J Hepatol       Date:  2011-12-13       Impact factor: 25.083

10.  Worldwide trends in mortality from biliary tract malignancies.

Authors:  Tushar Patel
Journal:  BMC Cancer       Date:  2002-05-03       Impact factor: 4.430
View more
  3 in total

1.  The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients.

Authors:  Bao Jin; Wenmo Hu; Si Su; Haifeng Xu; Xin Lu; Xinting Sang; Huayu Yang; Yilei Mao; Shunda Du
Journal:  Cancer Manag Res       Date:  2021-08-10       Impact factor: 3.989

2.  Controlling nutritional status score as a prognostic marker to predict overall survival in resected biliary tract cancers.

Authors:  Lejia Sun; Si Su; Jianping Xiong; Wenmo Hu; Lei Liu; Haifeng Xu; Shunda Du; Haitao Zhao; Xin Lu; Xinting Sang; Shouxian Zhong; Huayu Yang; Yilei Mao
Journal:  Ann Transl Med       Date:  2021-04

Review 3.  Significant Response to Camrelizumab Plus Targeted Drugs in Recurrent Intrahepatic Cholangiocarcinoma: a Case Report and Literature Review.

Authors:  Peixin Huang; Yingting Zhou; Yi Chen
Journal:  J Gastrointest Cancer       Date:  2021-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.